Canaccord Genuity Reiterates Verona Pharma Plc – ADR (VRNA) Buy Recommendation

Fintel reports that on September 1, 2023, Canaccord Genuity reiterated coverage of Verona Pharma Plc – ADR (NASDAQ:VRNA) with a Buy recommendation.

admin